Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Frontiers in Neurology
|
March 14, 2022
CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers
Stefanie Lerche, Milan Zimmermann, Isabel Wurster, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 27, 2018
Parkinson's disease: evolution of cognitive impairment and CSF Aβ<sub>1-42</sub> profiles in a prospective longitudinal study
Stefanie Lerche, Isabel Wurster, Benjamin Röben, et al.
NPJ Parkinson'S Disease
|
September 15, 2022
Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding
Isabel Wurster, Corinne Quadalti, Marcello Rossi, et al.
Plos One
|
September 24, 2013
Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study
Michelle M Mielke, Walter Maetzler, Norman J Haughey, et al.
Neurology and Therapy
|
May 27, 2026
Inter-assay and Inter-site Performance of Alpha-Synuclein Seed Amplification Assays in Synucleinopathies: A Multicenter 2 × 2 Protocol Comparison
Roger Plaza-Clar, Maximilian Weber, Vaibhavi Kadam, et al.
Current Alzheimer Research
|
March 15, 2016
Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease
Carlo Wilke, Frank Gillardon, Christian Deuschle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 26, 2016
Validating Alzheimer's disease micro RNAs using next-generation sequencing
Andreas Keller, Christina Backes, Jan Haas, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 1, 2019
Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha-Synuclein Profiles
Stefanie Lerche, Isabel Wurster, Benjamin Roeben, et al.
NPJ Parkinson'S Disease
|
January 19, 2024
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson's disease
Kathrin Brockmann, Stefanie Lerche, Simone Baiardi, et al.
Annals of Neurology
|
May 22, 2021
Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease
Sebastian Heinzel, Velma T E Aho, Ulrike Suenkel, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Frontiers in Neurology
|
March 14, 2022
CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers
Stefanie Lerche, Milan Zimmermann, Isabel Wurster, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 27, 2018
Parkinson's disease: evolution of cognitive impairment and CSF Aβ<sub>1-42</sub> profiles in a prospective longitudinal study
Stefanie Lerche, Isabel Wurster, Benjamin Röben, et al.
NPJ Parkinson'S Disease
|
September 15, 2022
Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding
Isabel Wurster, Corinne Quadalti, Marcello Rossi, et al.
Plos One
|
September 24, 2013
Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study
Michelle M Mielke, Walter Maetzler, Norman J Haughey, et al.
Neurology and Therapy
|
May 27, 2026
Inter-assay and Inter-site Performance of Alpha-Synuclein Seed Amplification Assays in Synucleinopathies: A Multicenter 2 × 2 Protocol Comparison
Roger Plaza-Clar, Maximilian Weber, Vaibhavi Kadam, et al.
Current Alzheimer Research
|
March 15, 2016
Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease
Carlo Wilke, Frank Gillardon, Christian Deuschle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 26, 2016
Validating Alzheimer's disease micro RNAs using next-generation sequencing
Andreas Keller, Christina Backes, Jan Haas, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 1, 2019
Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha-Synuclein Profiles
Stefanie Lerche, Isabel Wurster, Benjamin Roeben, et al.
NPJ Parkinson'S Disease
|
January 19, 2024
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson's disease
Kathrin Brockmann, Stefanie Lerche, Simone Baiardi, et al.
Annals of Neurology
|
May 22, 2021
Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease
Sebastian Heinzel, Velma T E Aho, Ulrike Suenkel, et al.
Page
of 6